Clinical Trial Update: A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for APG-2575 in combination with azacitidine in adults with acute myeloid leukemia, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• APG-2575
• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Ascentage Pharma Group Inc. | Conditions: AML, Adult | Phase 1, Phase 2 | Status: UNKNOWN